Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand - Wikidata - awgldk - TriplyDB

Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand

Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand

http://www.wikidata.org/entity/Q36154739

about

Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity Universal influenza vaccines, a dream to be realized soon.Consensus M2e peptide conjugated to gold nanoparticles confers protection against H1N1, H3N2 and H5N1 influenza A viruses.The prospects and challenges of universal vaccines for influenza An Influenza HA and M2e Based Vaccine Delivered by a Novel Attenuated Salmonella Mutant Protects Mice against Homologous H1N1 Infection.AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection.Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.Virus-like particles containing the tetrameric ectodomain of influenza matrix protein 2 and flagellin induce heterosubtypic protection in mice.Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection.Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway The minimalist architectures of viroporins and their therapeutic implications.Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.Hierarchical and Redundant Roles of Activating FcγRs in Protection against Influenza Disease by M2e-Specific IgG1 and IgG2a Antibodies.A dual purpose universal influenza vaccine candidate confers protective immunity against anthrax.Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice.Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination.Immune responses to oral and IM administration of M2e-Hsp70 construct.DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice

P2860

Q30357830-8E0B53F4-9258-46F9-AD5B-F89079F4D543 Q30361950-059FF2D1-677F-42E1-950C-24478279737F Q30398228-3CB3E90F-C6FB-4812-A2A1-4E6D3F22F865 Q30430703-3EBD824D-2788-49E7-889A-958DA7F94EEF Q33679360-C85E05E0-6149-49D1-B194-BFF17D90EEB2 Q34019854-661146F8-5F2D-48EF-911D-84387493DC63 Q36030772-50806F78-FDB7-4558-B699-1F5996CF7E02 Q36432748-1C064AFA-FF94-4983-891E-F0CFBDC3AAB1 Q37101184-2CA1634F-E871-4F61-9865-FF803A7F4F02 Q37210056-73DFB9C4-175F-449E-8DFC-A2336FAC4549 Q37587048-6A1C9B7B-531D-4835-9319-E494DB591AD6 Q37619619-E4783A98-32F8-4B8E-958A-2B3760AE9D24 Q40157020-7B752CC3-8F4C-4309-8086-E4CDF6B9E73F Q40375806-344DCB56-DB6B-4941-A022-B0094ABB10C0 Q40489092-321DD416-5ACC-4754-92C3-C855086DECDC Q40877967-B1630541-40E3-4AA6-B4DB-2793C5A67E35 Q42221819-E08F1E92-BD10-4AE2-9D6D-5DB318E29B57 Q42233708-09AE429C-ED2A-4503-9D0B-63373A17B12C Q52729536-48BE6FFC-74F4-4A25-8D1B-9CF3CE84F2A6 Q56221441-290D4066-1511-46C4-B7A1-AAF5D896E66F

P2860

Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand

http://www.wikidata.org/entity/Q36154739

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Enhanced influenza virus-like ...... nd a Toll-like receptor ligand

@ast

Enhanced influenza virus-like ...... nd a Toll-like receptor ligand

@en

type

label

Enhanced influenza virus-like ...... nd a Toll-like receptor ligand

@ast

Enhanced influenza virus-like ...... nd a Toll-like receptor ligand

@en

prefLabel

Enhanced influenza virus-like ...... nd a Toll-like receptor ligand

@ast

Enhanced influenza virus-like ...... nd a Toll-like receptor ligand

@en

P1433

Q36154739-529354AA-55CC-416A-B58F-6A3954D98E3D

P1476

Q36154739-D57D1B5D-6ACD-4B85-AD6D-A9B22B49A5CF

P2093

Q36154739-046B32B2-1C51-4D58-A561-C38269B966E1

Q36154739-4874C955-C175-4918-9E6E-B728DC7C9B4F

Q36154739-5AEF20B7-584D-48C9-97BA-280BA21D9AD1

Q36154739-B7765494-CAD8-4E97-A1CE-798DCD068E9B

Q36154739-CD1517A3-571B-4D78-B19F-1F56C4821A52

Q36154739-DEA8E214-9CDF-4C4C-8978-CA834F74E987

P2860

Q36154739-04AEE00E-A1BF-4B17-90C5-79BFF31993AB

Q36154739-065F9BB7-4078-422D-8E7E-B57AAED1177D

Q36154739-0D033654-9F8F-42DB-B3FA-2E352F848FC4

Q36154739-1723EB1B-AB46-45FE-A9E3-8C82F3EC2E8D

Q36154739-29849BA0-6482-4C7D-AF3A-748F1BCBEE37

Q36154739-2E2A0E5C-5DBC-4A6D-9706-F9086AF5CD37

Q36154739-3A6C2F4B-38C3-4638-9070-3C2C8D8D139E

Q36154739-3C3A9227-D9A9-4DA5-84A5-8E7DE61E9B14

Q36154739-3C9C3CDC-3651-402F-833B-EB7DC571EA3F

Q36154739-3D150B93-01EF-4D97-87E5-EF44A547D3C4

P304

Q36154739-CCF3BA86-CECC-45B2-922F-2D5F4DC20679

P31

Q36154739-B460D646-802C-4396-BB58-F6570A9AE633

P356

Q36154739-58ECD646-0929-4034-B354-659F2FDC848E

P433

Q36154739-2E29AB56-E07C-4372-BBEA-3054C9F83380

P478

Q36154739-8E874940-30D1-4CD8-9017-1CBF729A1193

P50

Q36154739-FDD46E28-BC6A-42F3-BF42-78A32E8CEA39

P577

Q36154739-3AC1C1ED-57C2-4998-ADA6-CF2EDB676B95

P698

Q36154739-C8922014-5AA0-4F1A-82A9-6D7F8972E275

P921

Q36154739-4E817922-711B-465B-8789-39FFFA62FEF2

Q36154739-93C588F8-A050-46D0-9E23-F629EB46AF92

P932

Q36154739-B42D783D-6119-4CFE-83E3-94DC3CE10A85

P356

P1433

Clinical and Vaccine Immunology

P1476

Enhanced influenza virus-like ...... nd a Toll-like receptor ligand

@en

P2093

Bao-Zhong Wang

http://www.w3.org/2001/XMLSchema#string

Elena V Vassilieva

http://www.w3.org/2001/XMLSchema#string

Harvinder S Gill

http://www.w3.org/2001/XMLSchema#string

Li Wang

http://www.w3.org/2001/XMLSchema#string

Sang-Moo Kang

http://www.w3.org/2001/XMLSchema#string

Ying-Chun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus

Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility

Evasion of Toll-like receptor 5 by flagellated bacteria.

Influenza virus-like particles containing M2 induce broadly cross protective immunity

Immunopotentiation of trivalent influenza vaccine when given with VAX102, a recombinant influenza M2e vaccine fused to the TLR5 ligand flagellin

Intranasal immunization with influenza VLPs incorporating membrane-anchored flagellin induces strong heterosubtypic protection

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

Influenza vaccine: the challenge of antigenic drift.

CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine.

Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses.

P304

1119-1125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.00153-12

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Richard W. Compans

P577

2012-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22647270

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

Toll-like receptor

P932

3416094

http://www.w3.org/2001/XMLSchema#string